Skip to content
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
Newsroom
Explore the latest breakthroughs, insights, and stories from behind the scenes at EffRx Pharmaceuticals.
January 23, 2025
|
Press Releases
EffRx Pharmaceuticals Recognized for Sustainability Excellence with EcoVadis Silver Medal
January 7, 2025
|
News
,
Newsroom
EffRx Joins scienceindustries (the Swiss Business Association Chemistry Pharma Life Sciences)
December 5, 2024
|
News
,
Newsroom
EffRx Joins SHQA (swiss health quality association)
June 3, 2024
|
News
,
Newsroom
EffRx Attending the BIO International Convention in San Diego
May 7, 2024
|
Press Releases
EffRx Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement with Pyridam Farma for Commercialization of BINOSTO® in Indonesia
April 8, 2024
|
News
,
Newsroom
EffRx Attending the 2024 WCO IOF-ESCEO Congress in London
February 28, 2024
|
News
,
Newsroom
EffRx is a Proud Supporter of Rare Disease Day, Taking Place on February 28
February 6, 2024
|
Press Releases
EffRx Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement with Lupin for Commercialization of BINOSTO® in Vietnam & Philippines
January 25, 2024
|
News
,
Newsroom
EffRx Attending the Annual Meeting SSEDP / SGPED on 25. January 2024 in Berne
September 29, 2023
|
Press Releases
EffRx Pharmaceuticals Signs Exclusive Licensing Agreement With Radius Health To Commercialize BINOSTO® In The United States
July 12, 2023
|
News
World Orphan Drug Alliance (WODA) Marks their First Anniversary
May 29, 2023
|
Press Releases
Abiogen Pharma Completes the Acquisition of EffRx
May 4, 2023
|
News
EffRx Attends the WCO IOF-ESCEO Congress
February 21, 2023
|
News
EffRx Supports the 16th Annual Rare Disease Day on 28. February 2023
January 24, 2023
|
News
EffRx Attending the Annual Meeting SSEDP / SGPED on 26. January 2023 at the Universitäts-Kinderspital Zürich
December 20, 2022
|
News
EffRx Attends the 1st Eastern Switzerland Symposium on Rare Diseases in St. Gallen, Switzerland
July 20, 2022
|
Press Releases
EffRx Pharmaceuticals announces the launch of Alkindi® as replacement therapy for pediatric adrenal insufficiency in Switzerland
July 20, 2022
|
Press Releases
World Orphan Drug Alliance – combining forces to reach patients with rare diseases across the globe
July 13, 2022
|
News
EffRx Attending the 9th I-DSD Symposium 2022 in Bern, Switzerland, University Hospital Bern from 14-16th July 2022
July 6, 2022
|
News
EffRx Featured as Member of WODA in Rare Revolution Magazine
April 26, 2022
|
Press Releases
EffRx Pharmaceuticals Signs Exclusive License Agreement with Diurnal for the Registration and Commercialization of Efmody® in Switzerland
April 7, 2022
|
News
EffRx Exhibiting at the Austrian-Swiss Metabolic Meeting in Zürich on the 7th and 8th of April 2022
February 28, 2022
|
News
EffRx Supports the 15th Annual Rare Disease Day on 28. February 2022
January 20, 2022
|
News
EffRx Attending the Annual Meeting SSEDP / SGPED on 20. January 2022 in St. Gallen
June 9, 2021
|
News
EffRx Seeks New Business Collaborations at the BIO International Convention Digital 2021
May 25, 2021
|
News
Dr. Nathalie Véron Appointed Director Technical Operations & Qualified Person at EffRx Pharmaceuticals
February 15, 2021
|
News
EffRx Pharmaceuticals Announces the Release of Binosto® Data in Two Publications
November 18, 2020
|
News
EffRx Pharmaceuticals Signs Exclusive License Agreement with Dipharma SA and Launches Miglustat Dipharma in Switzerland
August 18, 2020
|
News
World Osteoporosis Day – WOD marked on October 20th: THAT’S OSTEOPOROSIS
February 19, 2020
|
News
The 13th international Rare Disease Day coordinated by EURORDIS will be on February 29, 2020
January 8, 2020
|
News
EffRx Pharmaceuticals Attending the 38th Annual J.P. Morgan Healthcare Conference from January 13-16, 2020 in San Francisco
